Clinical Trial: Comprehensive Frailty Assessment

Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Observational

Official Title: Comprehensive Frailty Assessment

Brief Summary: The purpose of this research study is to describe a patients' fitness before and after treatment (whether that treatment be chemotherapy or a transplant). Fitness is a way of measuring a patient's current quality of health. With surveys, questionnaires and blood tests, we hope to create a tool that will give a good picture of patients' ability to tolerate treatment. In the future, we hope to devise the best treatment for a patient based on their "fitness".

Detailed Summary:
Sponsor: Ohio State University Comprehensive Cancer Center

Current Primary Outcome: Change in Comprehensive Frailty Assessment [ Time Frame: up to 14 months ]

Responses to the Comprehensive Frailty Assessment will be assessed before and after treatment and changes will be evaluated. In transplant patients, this will be measured one year post transplant and in the non-transplant arm, this will be assessed after the second cycle of treatment.


Original Primary Outcome: Same as current

Current Secondary Outcome: Time to progression [ Time Frame: date of enrollment to date of documented clinical progression up to two years post-enrollment ]

We will assess time to progression for multiple myeloma patients and the relationships of those outcomes to patients' functional, cognitive and psychosocial health.


Original Secondary Outcome: Same as current

Information By: Ohio State University Comprehensive Cancer Center

Dates:
Date Received: December 18, 2013
Date Started: April 2014
Date Completion:
Last Updated: September 21, 2016
Last Verified: September 2016